InvestorsHub Logo
Followers 10
Posts 1040
Boards Moderated 0
Alias Born 07/08/2006

Re: dr_lowenstein post# 296400

Wednesday, 08/01/2018 11:04:46 PM

Wednesday, August 01, 2018 11:04:46 PM

Post# of 402106
Well, there was that 163 person PIII efficacy study conducted with no adverse affects according to a PR released by Elite. And then there was the small pilot study completed this year and again. . .no adverse affects. I will go with the info provided by Elite unless other sources can prove otherwise.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News